The lincomycin hydrochloride narrow-spectrum antibiotic
has a similar effect to erythromycin
, and has a better effect on gram-positive cocci, and is particularly effective against anaerobic bacteria, staphylococcus aureus, and pneumococcus.
Lincomycin antibiotics include lincomycin and clindamycin. Its mechanism of action is similar to that of macrolides, and it can also irreversibly bind to the 50S subunit of bacterial ribosomes, inhibiting bacterial protein synthesis by blocking transpeptide action and mRNA displacement. Clindamycin is 4-8 times stronger than lincomycin, has a strong antibacterial effect on various anaerobic bacteria, has significant activity on aerobic gram-positive bacteria, and is partially active on aerobic gram-negative cocci, humans Mycoplasma and Chlamydia trachomatis also have inhibitory effects, but enterococci, gram-negative bacilli, methicillin-resistant Staphylococcus aureus (MRSA
), and mycoplasma pneumoniae are not sensitive to this class of drugs.
Lincomycin injection is used for sensitive staphylococcus, streptococcus, pneumococcus and anaerobic respiratory infections, skin and soft tissue infections, female reproductive tract infections, pelvic infections, and abdominal infections. Depending on the situation, this product can be used alone or in combination with other antibacterial drugs. In addition, patients with indications for penicillin use, such as patients who are allergic to penicillin or should not use penicillin, this product can be used as an alternative medicine.
Applicable to sensitive Staphylococcus, Streptococcus, Streptococcus pneumoniae and anaerobic bacteria caused by respiratory infections, skin and soft tissue infections, female reproductive tract infections and pelvic infections and abdominal infections, etc. This product may be used in combination with other antibacterial drugs.
Lincomycin 300 Injectable is indicated for the treatment of infectious forms of arthritis caused by susceptible organisms and for mycoplasma pneumonia.